Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697451 | SCV000717326 | likely benign | not provided | 2020-05-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001697451 | SCV002406691 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002245044 | SCV002514317 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279397 | SCV002565415 | uncertain significance | Ehlers-Danlos syndrome | 2019-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413708 | SCV002675782 | likely benign | Cardiovascular phenotype | 2020-09-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002245044 | SCV002805824 | likely benign | Brittle cornea syndrome 1 | 2021-12-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003915774 | SCV004737145 | benign | ZNF469-related disorder | 2019-05-02 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |